TNF and Cowden disease: In both, 280 adult patients with moderate to severe CD and an inadequate response to or intolerance of previously administered immunomodulators (TNF inhibitors, corticosteroids) were randomized to receive induction therapy for 8 weeks with placebo or tofacitinib 5 or 10 mg twice daily.